Relating To Cognitive Assessments.
HB700 establishes a new state framework aimed at improving the early detection of Alzheimer’s disease and related dementias among Medicare beneficiaries in Hawaii. The bill requires standardized, validated cognitive assessments to be used during annual wellness visits covered by Medicare Part B and Part C, subject to specified exceptions. A qualified patient may decline the assessment after being informed of its purpose, benefits, and risks, and the bill excludes providers who do not accept Medicare, patients already diagnosed with dementia or mild cognitive impairment, and patients unable to undergo the assessment because of a physical or mental impairment or disability.
The bill also creates a two-year dementia data pilot program within the Executive Office on Aging. Participating providers may submit annual reports containing de-identified information such as whether the patient declined or was exempt, the date and location of the assessment, demographic information, the type and result of the assessment, and any follow-up actions. The Executive Office on Aging must compile and report aggregated findings to the Legislature in 2027 and 2028, and the reports must be publicly available while protecting patient confidentiality.
HB700 amends Chapter 349, Hawaii Revised Statutes, by adding a new part governing cognitive assessments for Medicare beneficiaries and by assigning the Executive Office on Aging responsibility for a dementia data pilot program. It standardizes how cognitive screening is to be performed at annual wellness visits for eligible Medicare Part B and Part C patients, while preserving patient choice and creating exemptions for certain providers and patients. The bill also imposes reporting, data security, and confidentiality requirements, and it directs the revisor of statutes to codify the new sections appropriately. The practical effect is to expand and formalize cognitive screening practices in primary care settings and to create a temporary state data-collection mechanism to support dementia policy planning.
The overall sentiment appears strongly supportive and largely noncontroversial. The bill advanced through multiple Senate committees and conference votes unanimously or near-unanimously, with no recorded nays in the provided voting history. The findings section reflects a public health and cost-savings rationale, emphasizing early detection, caregiver burden, and the state’s aging population. The lack of committee transcript material suggests no significant public debate is available in the record provided, but the voting pattern indicates broad bipartisan or cross-committee agreement.
The main potential points of contention are privacy, scope, and implementation. The bill authorizes collection of sensitive demographic and clinical information, including age, zip code, race, gender, assessment results, and follow-up actions, which raises confidentiality and data-security concerns even though the bill requires aggregation and de-identification in public reports. Another possible issue is the mandate-like effect on providers and annual wellness visits, though the bill limits its reach to Medicare-participating providers and allows patients to decline the assessment. The bill also excludes patients already diagnosed with dementia or mild cognitive impairment and those unable to participate due to disability, which helps narrow the mandate but may also limit the program’s reach.